MONOVER

This brand name is authorized in France, Ireland, Japan, Poland.

Active ingredients

The drug MONOVER contains one active pharmaceutical ingredient (API):

1	Ferric derisomaltose UNII AHU547PI9H - FERRIC DERISOMALTOSE
	Ferric derisomaltose is a complex of iron (III) hydroxide and derisomaltose, an iron carbohydrate oligosaccharide that releases iron. Iron binds to transferrin for transport to erythroid precursor cells to be incorporated into hemoglobin. It is used for the treatment of iron deficiency anemia (IDA) in adult patients.

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MONOVER Solution for injection / infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B03AC	Iron trivalent, parenteral preparations	B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations
Discover more medicines within B03AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	60717355
JP	医薬品医療機器総合機構	3222405A1026, 3222405A2022
PL	Rejestru Produktów Leczniczych	100225428